18~65岁人群重组结核杆菌融合蛋白皮肤试验应用剂量及在3~17岁和66~75岁人群中的安全性:一项随机、盲法、阳性对照Ⅱ期临床试验
王敬, 王庆枫, 荆玮, 王宇津, 王雪钰, 黄海荣, 初乃惠, 聂文娟
Dosage of recombinant Mycobacterium tuberculosis fusion protein for skin testing in the 18-65 year-old population and its safety in the 3-17 and 66-75 year-old populations: a randomized, blinded, positive-controlled phase Ⅱ clinical trial
Wang Jing, Wang Qingfeng, Jing Wei, Wang Yujin, Wang Xueyu, Huang Hairong, Chu Naihui, Nie Wenjuan
中国防痨杂志
.
2025, (7): 840
-845
.
DOI: 10.19982/j.issn.1000-6621.20250067
京公网安备11010202007215号
ip访问总数: ip当日访问总数: 当前在线人数:
本作品遵循Creative Commons Attribution 3.0 License授权许可